about us main logo
pipeline
technology
investorinfo

nnvcinthenews

NanoViricides Inc.

1 Controls Drive,
Shelton, CT 06484
Ph No:- 203-937-6137
Fax No:- 203-859-5095
Email:- info@nanoviricides.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Welcome

Welcome to NanoViricide's Investor Relations section.

NanoViricides, Inc. is a leading company in the application of nanomedicine technologies to the complex issues of viral diseases. The nanoviricide® technology permits direct attacks at multiple points on a virus particle. It is believed that such actions lead to the virus particle becoming ineffective at infecting cells. Antibodies in contrast attack a virus particle at only a maximum of two attachment points per antibody.

We have been aggressively expanding our portfolio of virus targets and drug candidates every year since our inception in May, 2005.

Most Recent Presentation

"PENICILLIN" FOR VIRUSES
Eradicating Diseases Caused by Viruses Using 21st Century Technology
Presented by: Eugene Seymour, MD, MPH
Chief Executive Officer
June - 2016

Most Recent Fact Sheet

Nanoviricides Inc Fact Sheet: January 24th, 2016


Most Recent Press Releases

 


stocksymbolheader

 




nnvcinthenews

04-15-2014 NanoViricides won the IAIR AWARD
NanoViricides won the IAIR AWARD as Best North American Company for Leadership in the Nanomedicine Sector.
02-20-2014Dr. Anil R. Diwan Recognized as            "Researcher of the year".
NanoViricides, Inc. President Dr. Anil R. Diwan Recognized as "Researcher of the Year" by BusinessNewHaven, a Connecticut Area Business Journal.

 

 

 

 

 

 

 

 

 

 

 

 

 



Contact Information

NanoViricides, Inc.
1 Controls Drive,
Shelton, CT 06484

Phone: +1-203-937-6137
Phone: +1-888-591-3579
Fax: +1-203-859-5095
E-mail: info@nanoviricides.com